相似文献
1
Tamoxifen Therapy for Breast Cancer and Endometrial Pathology.
Med J Armed Forces India. 2005 Oct;61(4):313-5. doi: 10.1016/S0377-1237(05)80052-8. Epub 2011 Jul 21.
2
Transvaginal endometrial sonography in postmenopausal women taking tamoxifen.
Obstet Gynecol. 1999 Mar;93(3):363-6. doi: 10.1016/s0029-7844(98)00418-9.
3
Sonographic, hysteroscopic, and histologic evaluation of the endometrium in postmenopausal women with breast cancer receiving tamoxifen.
J Am Assoc Gynecol Laparosc. 2000 Feb;7(1):77-81. doi: 10.1016/s1074-3804(00)80013-4.
4
Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
J Am Assoc Gynecol Laparosc. 1997 May;4(3):331-9. doi: 10.1016/s1074-3804(05)80224-5.
5
Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Ultrasound Obstet Gynecol. 1995 Dec;6(6):435-42. doi: 10.1046/j.1469-0705.1995.06060435.x.
6
Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Eur J Obstet Gynecol Reprod Biol. 2007 May;132(1):101-6. doi: 10.1016/j.ejogrb.2006.04.001. Epub 2006 May 5.
7
[Tamoxifen and endometrial pathology].
Rev Med Chir Soc Med Nat Iasi. 2010 Oct-Dec;114(4):1114-7.
8
Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen.
Int J Gynaecol Obstet. 1999 Nov;67(2):81-6. doi: 10.1016/s0020-7292(99)00124-1.
9
Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Clin Cancer Res. 2006 Feb 15;12(4):1245-50. doi: 10.1158/1078-0432.CCR-05-0225.
10
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Hum Reprod. 2005 Jan;20(1):294-301. doi: 10.1093/humrep/deh567. Epub 2004 Oct 28.
引用本文的文献
1
Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy.
J Midlife Health. 2015 Apr-Jun;6(2):59-65. doi: 10.4103/0976-7800.158947.
2
Uterine changes during tamoxifen, toremifene, and other therapy for breast cancer: evaluation with magnetic resonance imaging.
Jpn J Radiol. 2010 Jul;28(6):430-6. doi: 10.1007/s11604-010-0446-9. Epub 2010 Jul 27.
本文引用的文献
1
Tamoxifen therapy for breast cancer and endometrial cancer risk.
J Natl Cancer Inst. 1999 Oct 6;91(19):1654-62. doi: 10.1093/jnci/91.19.1654.
2
Tamoxifen and endometrial pathologies: a prospective study.
Gynecol Oncol. 1999 Oct;75(1):15-9. doi: 10.1006/gyno.1999.5519.
3
Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients.
J Clin Pathol. 1999 Apr;52(4):278-82. doi: 10.1136/jcp.52.4.278.
4
Association between endometrial cancer and tamoxifen treatment of breast cancer.
Breast Cancer Res Treat. 1999 Apr;54(3):255-60. doi: 10.1023/a:1006126411210.
5
Surveillance for endometrial cancer in women receiving tamoxifen.
Ann Intern Med. 1999 Jul 20;131(2):127-35. doi: 10.7326/0003-4819-131-2-199907200-00009.
6
Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen.
Eur J Gynaecol Oncol. 1998;19(6):580-3.
7
The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Cancer. 1998 May 1;82(9):1698-703.
8
Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
AJR Am J Roentgenol. 1997 Mar;168(3):657-61. doi: 10.2214/ajr.168.3.9057510.
9
Overview of studies on endometrial cancer and other types of cancer in humans: perspectives of an epidemiologist.
Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-122-S1-39.
Zotero 插件